Well said Chuxa - can’t reply directly.
I think everyone is missing the theme here. There’s been a huge upfront investment in European expansion. That was clearly apparent in some of the recent financial reports. This is an investment in people, marketing, rent, stock etc ie EXPENSES!!!
While I won’t go so far to say that this is a positive announcement I will say that the risk v reward at this level is highly skewed to the upside. This is an $18m EV business. With very conservative assumptions the NPV of the Certus contract is about $7m so that implies the whole business with stock, ARR, shell value is worth $11m. If anyone can clearly argue that this is over valued at this level please feel free to make your points.
I will say though that my TP estimates are likely to be delayed but I’m prepared to be patient here. Not much effort for 1-3 bags at this level. I am also very glad that they invested in stock given supply chain challenges
Travelling atm so will do a deeper dive when I’m back in the country.
- Forums
- ASX - By Stock
- BCC
- Ann: Trading Update for FY2022 and FY2023
Ann: Trading Update for FY2022 and FY2023, page-15
-
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCC (ASX) to my watchlist
|
|||||
Last
14.5¢ |
Change
-0.015(9.38%) |
Mkt cap ! $12.53M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 14.5¢ | $2.467K | 15.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 140000 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 19766 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 140000 | 0.140 |
1 | 22499 | 0.135 |
2 | 59099 | 0.110 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 19766 | 1 |
0.165 | 8000 | 1 |
0.170 | 1003 | 1 |
0.185 | 7500 | 1 |
0.190 | 20000 | 1 |
Last trade - 14.19pm 15/07/2024 (20 minute delay) ? |
Featured News
BCC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online